VALEANT PHARMACEUTICALS INTL
COM · CUSIP 91911K102
1
institutional holders
931.0k
shares reported held*
$6.4mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $6.89.
Holders, Q3 2022
| Manager | Shares | Change |
|---|---|---|
| Bruce & Co., Inc. 1.76% of their portfolio | 931.0k $6.4m | — |